1. Home
  2. Programs
  3. Heart Matters
advertisement

Tirzepatide reduces HF events in patients with HFpEF and obesity

Milton Packer at AHA
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters

  • Overview

    AHA 2024 - Milton Packer shares the results of the SUMMIT trial, in which the efficacy of the dual GIP/GLP-1RA tirzepatide was examined in patients with HFpEF and obesity. He says: “This is really very exciting news and information. We think it would change the practice of how these patients are treated in the future.”

  • Educational information

    This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.

  • Faculty

    Milton Packer, MD, is an internationally recognized clinical investigator in the field of heart failure. He spent most of this career in New York City, where he was the Dickinson Richards Professor and Chief of the Division of CIrculatory Physiology at Columbia University. From 2004-2015 he was Professor and Chair of the Department of Clinical Sciences at the University of Texas Southwestern Medical Center at Dallas. Dr. Packer is currently the Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center, part of Baylor Scott & White Health.

  • Disclaimer

Recommended
Details
Presenters

  • Overview

    AHA 2024 - Milton Packer shares the results of the SUMMIT trial, in which the efficacy of the dual GIP/GLP-1RA tirzepatide was examined in patients with HFpEF and obesity. He says: “This is really very exciting news and information. We think it would change the practice of how these patients are treated in the future.”

  • Educational information

    This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.

  • Faculty

    Milton Packer, MD, is an internationally recognized clinical investigator in the field of heart failure. He spent most of this career in New York City, where he was the Dickinson Richards Professor and Chief of the Division of CIrculatory Physiology at Columbia University. From 2004-2015 he was Professor and Chair of the Department of Clinical Sciences at the University of Texas Southwestern Medical Center at Dallas. Dr. Packer is currently the Distinguished Scholar in Cardiovascular Science at Baylor University Medical Center, part of Baylor Scott & White Health.

  • Disclaimer

Program Chapters

Segment Chapters

Playlist:

advertisement

Recommended

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
PrevNext